How do you counsel patients who inquire about response rates in metastatic breast cancer?
Do you tailor treatment to a goal response? Do you refer to data illustrating improved prognosis if the patient develops a CR or PR?
Answer from: Medical Oncologist at Academic Institution
I typically explain what response rate, response duration and progression free survival means and make sure that patients are aware that the outcome of interest reported in clinical trial represents a mean value and that patients enrolled in the study had a range of responses, some were better than ...
Comments
Medical Oncologist at NYU Winthrop Hospital Breast Cancer is a heterogeneous disease. We have ...
Breast Cancer is a heterogeneous disease. We have ...